Dr. Barry Borlaug and Dr. C. Michael Gibson Discuss: Semaglutide Ameliorates the Seminal Hemodynamic Features of Obesity-Related HFpEF: A Placebo Controlled Randomized Clinical Trial November 8, 2026 2026 | AHA | Slides | Trial | Video Borlaug AHA 2026Download Disclosures: TBD Article Navigation Dr. Gregory Lewis and Dr. C. Michael Gibson Discuss: IRONMET-HFpEF (Impact of Intravenous Iron Repletion on Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: The IRONMET-HFpEF Trial Primary Results) Dr. Sharine Wittkopp and Dr. C. Michael Gibson Discuss: Cleaner Air for Lower Cardiometabolic Risk: A Randomized, Double-Blind, Sham-Controlled Trial of Air Pollution Reduction
